This is a firm fixed price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. for INFINIUM METHYLATION EPIC 96SAMPLES, which are genomic sequencing services and products. The total ceiling value of the award is $153,584.64, with a completion date of September 15, 2016. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has previously...
This is a firm fixed price delivery order awarded by the National Human Genome Research Institute, a civilian agency, to Illumina, Inc. for the procurement of 96-sample INF methylationEPIC v2.0 kits. The $38,823.75 contract has a completion date of September 2, 2025 and does not have a set-aside designation. Illumina is a manufacturer of genetic and genomic analysis instruments and reagents, and has previously provided sequencing systems, consumables, and related services to federal agencies...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Human Genome Research Institute awarded a firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. Under this $239,790.10 award, Illumina will provide INFINIUM METHYLATIONEPIC BEADCHIP kits for 16 samples. The contract has no set-aside designation and a completion date of September 2, 2025. Illumina has previously supported...
This federal contract award, valued at $76,003.20, was issued by the National Human Genome Research Institute (NHGRI) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The award provides for the delivery of INF METHYLATIONEPIC V2.0 KIT (96 SPL) products, which are likely sequencing kits used to support genomic research and analysis. The contract is a firm fixed price delivery order, with a period of performance extending to September 2, 2025. Illumina has...
The U.S. Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, in the amount of $101,836.80. The purchase order is for Infinium Methylation EPIC BeadChip products. This award does not have a set-aside designation. Illumina has previously received prime contracts and...
This is a $75,202.56 firm fixed price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The award provides 4 units of 96 HumanMethylation 450K DNA Analysis BeadChip Kits with reagents for the NCI Cancer Genomics Research Laboratory. This purchase is not associated with a larger contract vehicle and does not have a set-aside designation. Illumina has...
This firm fixed-price delivery order was awarded by the National Institute on Aging (a civilian agency within the U.S. Department of Health and Human Services) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $118,914.05 contract is for the provision of "INFINIUM METHYLATION EPIC 96 SAMPLES", a product related to methylation analysis. There is no set-aside designation for this award. Illumina has previously received prime...
This is a $103,520.31 firm fixed price delivery order awarded by the National Institute on Aging (NIA), a civilian agency, to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The award is for the provision of Illumina's Infinium Methylation Array, targeting 830,000 methylation sites, with a performance period ending on March 25, 2016. This contract has no set-aside designations. Illumina has previously received prime federal contracts and...
This is a firm fixed-price delivery order awarded by the National Institute of Environmental Health Sciences, a civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $78,703.47 contract is not associated with a set-aside. Illumina has previously received prime and subcontract awards from federal agencies such as the NIH, CDC, USDA, and VA to provide sequencing instruments, consumables, and bioinformatics support for genomic research and diagnostic...
This federal contract award was issued by the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $84,662.41 firm fixed price delivery order was awarded on September 26, 2015, with a completion date of September 2, 2020. The award does not mention any set-aside provisions. Under this contract, Illumina provided NIEHS with...